Next generation treatment of pancreatic cancer
Xerient is focused on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers.
Xerient is pursuing the development of novel therapeutics and diagnostic technologies that can dramatically improve the survival of these patients.
Partners
